Risankizumab versus Ustekinumab bei Morbus Crohn
Crossref DOI link: https://doi.org/10.1007/s15036-024-3793-6
Published Online: 2024-12-12
Published Print: 2024-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Stange, Eduard F.
Text and Data Mining valid from 2024-12-01
Version of Record valid from 2024-12-01
Article History
First Online: 12 December 2024